Appropriate risk stratification in patients considered at increased risk of sudden arrhythmic death is still an unsolved challenge, and the benefit of ICD therapy depends upon reliable risk assessment. Evaluation of clinical, hemodynamic and electrocardiographic risk parameters is time consuming and warrants immediate defibrillation when necessary. The Wearable Cardioverter Defibrillator (WCD) is an approach that allows planned risk assessment while continuously protecting the patient from sudden arrhythmic death.The purpose of this part of the Webinar is :
Christian Perings and Lucas Boersma discuss Managing the Risk of Sudden Cardiac Death using a Wearable Cardioverter Defibrillator
ESC Guidelines on Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
The EHRA Webinars are designed to help you improve your daily practice!The format includes a case based presentation, online assessment and live discussions with the 2 key opinion leaders who will give you some useful tips for your daily clinical practice.
European Society of Cardiology
European Heart HouseLes Templiers2035 Route des CollesCS 80179 Biot
06903, Sophia Antipolis, FR
This programme is supported by Zoll in the form of unrestricted educational grants. The EHRA Webinar 2014 scientific programme has not been influenced in any way by its sponsors.
Our mission: To reduce the burden of cardiovascular disease.
© 2019 European Society of Cardiology. All rights reserved.